Clinical trial
Electrolysis Percutaneous Therapeutic (EPTE) for the Management of Supraspinatus Tendinopathy
NCT02196948 is registered in ClinicalTrials.gov with Universidad Rey Juan Carlos as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Electrolysis Percutaneous Therapeutic (EPTE) for the Management of Supraspinatus Tendinopathy
- Lead sponsor
- Universidad Rey Juan Carlos
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- December 31, 2014
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
supraspinatus tendinopathy